TY - JOUR T1 - Going by the Numbers : Learning and Modeling COVID-19 Disease Dynamics JF - medRxiv DO - 10.1101/2020.05.18.20106112 SP - 2020.05.18.20106112 AU - Sayantani Basu AU - Roy H. Campbell Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/22/2020.05.18.20106112.abstract N2 - The COrona Virus Disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a challenging number of infections and deaths worldwide. In order to combat the pandemic, several countries worldwide enforced mitigation measures in the forms of lockdowns, social distancing and disinfection measures. In an effort to understand the dynamics of this disease, we propose a Long Short Term Memory (LSTM) based model. We train our model on over three months of cumulative COVID-19 cases and deaths. Our model can be adjusted based on the parameters in order to provide predictions as needed. We provide results at both the country and county levels. We also perform a quantitative comparison of mitigation measures in various counties in the United States based on the rate of difference of a short and long window parameter of the proposed LSTM model. The analyses provided by our model can provide valuable insights based on the trends in the rate of infections and deaths. This can also be of help for countries and counties deciding on mitigation and reopening strategies. We believe that the results obtained from the proposed method will contribute to societal benefits for a current global concern.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCOVID-19 Public Data: https://github.com/CSSEGISandData/COVID-19, Proposed Model Source Code: https://github.com/sayantanibasu/covid19-models https://github.com/CSSEGISandData/COVID-19 https://github.com/sayantanibasu/covid19-models ER -